Product Description
.From the Western scientific perspective the fate of cholesterol held in LDL carriers is to be ingested by macrophages in arterial walls and ultimately to end up as plaque. In this process the arteries become less compliant and smaller in diameter leading to higher blood pressures to achieve normal blood flows. The fate of cholesterol in HDL carriers is to be taken up and metabolized by the liver. HDLs have been shown to scavenge cholesterol from LDL carriers and plaques. Saturated fat in the diet prevents normal HDL uptake and activity and has been shown to be the main cause of atherosclerosis in normal individuals. Maximizing the liver's ability to produce HDL carriers and to maximize their function in the blood can reverse some of the plaque development and high blood pressure in many individuals.
The target of this formula is the otherwise normal individual who has elevated blood pressure and high blood cholesterol. The goal is to prevent further pathology from occurring and to reverse where possible the pathology that may already have already occurred.
Modern acute care clinical research in China shows that this formula has remarkable effects dilating the coronary arteries, increasing the volume of coronary artery blood flow, and raising the cardiac muscle's tolerance of hypoxia. It inhibits thrombosis formation, promotes fibrinolysis (clot dissolving), inhibits platelet aggregation, and promotes the restoration of necrotic cardiac muscle tissue. This formula very effectively addresses the widest range of these pathologies and effectively prevents worsening of symptoms associated with this disease and also can bring about significant resolution.
Trilight, Inc. had a CA FDA approved facility, and is a licensed Organic food handler & celebrates over 17 years in business.
If you have product questions we can be reached by calling 530-292-1236 from 9-3:30 PST M-F.